NASDAQ
VRNA

Verona Pharma PLC ADR

PHARMACEUTICAL PREPARATIONS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Verona Pharma PLC ADR Stock Price

Vitals

Today's Low:
$12.7301
Today's High:
$13.6000
Open Price:
$13.3500
52W Low:
$3.408
52W High:
$14.69
Prev. Close:
$13.1900
Volume:
360921

Company Statistics

Market Cap.:
$0.790 billion
Book Value:
1.828
Revenue TTM:
$0.040 billion
Operating Margin TTM:
-127.6%
Gross Profit TTM:
$0.040 billion
Gross Profit TTM:
$0.040 billion
Profit Margin:
-137%
Return on Assets TTM:
-17.1%
Return on Equity TTM:
-41.3%

Company Profile

Verona Pharma PLC ADR had its IPO on 2017-04-27 under the ticker symbol VRNA.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Verona Pharma PLC ADR has a staff strength of 0 employees.

Stock update

Shares of Verona Pharma PLC ADR opened at $13.35 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $12.73 - $13.6, and closed at $12.97.

This is a -1.71% slip from the previous day's closing price.

A total volume of 360,921 shares were traded at the close of the day’s session.

In the last one week, shares of Verona Pharma PLC ADR have increased by +17.86%.

Verona Pharma PLC ADR's Key Ratios

Verona Pharma PLC ADR has a market cap of $0.790 billion, indicating a price to book ratio of 7.04 and a price to sales ratio of 19.76.

In the last 12-months Verona Pharma PLC ADR’s revenue was $0.040 billion with a gross profit of $0.040 billion and an EBITDA of $-0.050 billion. The EBITDA ratio measures Verona Pharma PLC ADR's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Verona Pharma PLC ADR’s operating margin was -127.6% while its return on assets stood at -17.1% with a return of equity of -41.3%.

In Q2, Verona Pharma PLC ADR’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Verona Pharma PLC ADR’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
0

Its diluted EPS in the last 12-months stands at $-0.993 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Verona Pharma PLC ADR’s profitability.

Verona Pharma PLC ADR stock is trading at a EV to sales ratio of 16.86 and a EV to EBITDA ratio of -12.54. Its price to sales ratio in the trailing 12-months stood at 19.76.

Verona Pharma PLC ADR stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Verona Pharma PLC ADR ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Verona Pharma PLC ADR ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Verona Pharma PLC ADR’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Verona Pharma PLC ADR's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Verona Pharma PLC ADR paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$12.97
52-Week High
$14.69
52-Week Low
$3.408
Analyst Target Price
$26

Verona Pharma PLC ADR stock is currently trading at $12.97 per share. It touched a 52-week high of $14.69 and a 52-week low of $14.69. Analysts tracking the stock have a 12-month average target price of $26.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Verona Pharma PLC ADR

The stock symbol (also called stock or share ticker) of Verona Pharma PLC ADR is VRNA

The IPO of Verona Pharma PLC ADR took place on 2017-04-27

Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)

Last Price
Chg
Chg%
$1.9
0
0%
$113.94
-2.77
-2.37%
$0.53
-0
-0.36%
Pulmatrix Inc (PULM)
$3.48
-0.16
-4.4%
$0.49
0.02
+4.03%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Verona Pharma plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company is headquartered in London, the United Kingdom.

Address

3 MORE LONDON RIVERSIDE, LONDON, GB